Sulforaphane ( DrugBank: Sulforaphane )


2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
6パーキンソン病1
205脆弱X症候群関連疾患1

6. パーキンソン病


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05084365
(ClinicalTrials.gov)
October 10, 20217/10/2021A 6-month Study to Evaluate Sulforaphane Effects in PD PatientsA 6-month Study to Evaluate Sulforaphane Effects in Treatment of Cognition Impairment of PD PatientsParkinson DiseaseDrug: Sulforaphane;Drug: PlaceboCentral South UniversityNULLNot yet recruiting40 Years75 YearsAll100Phase 2NULL

205. 脆弱X症候群関連疾患


臨床試験数 : 5 薬物数 : 7 - (DrugBank : 5) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 25
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05233579
(ClinicalTrials.gov)
June 25, 202120/10/2021Open-Label Trial of Sulforaphane in Premutation Carriers With FXTASOpen-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find BiomarkersFragile X Associated Tremor/Ataxia Syndrome (Fxtas) (Diagnosis)Dietary Supplement: SulforaphaneUniversity of California, DavisNULLRecruiting50 Years85 YearsAll15N/AUnited States